Drawing for PHARMACEUTICAL PRESS ESSENTIAL KNOWLEDGE

USPTO serial 79405830

PHARMACEUTICAL PRESS ESSENTIAL KNOWLEDGE

Reviewed by CopyMark Law Group

Reg. 7683364Status 700Registered
Filing date
Status date
Registration date
Feb 11, 2025
Examiner
LEHKER, DAWN FELDMAN
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PHARMACEUTICAL PRESS ESSENTIAL KNOWLEDGE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Shoko Naruo

Shoko Naruo Thompson Coburn LLPOne US Bank PlazaSt. Louis, MO 63101United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software for database management, use searching data and information contained in electronic publications in the field of medicine, pharmacy and pharmacology; downloadable software applications for database management, use searching data and information contained in electronic publications in the field of medicine, pharmacy and pharmacology; downloadable workflow management application software for database management, use searching data and information contained in electronic publications in the field of medicine, pharmacy and pharmacology; downloadable workflow management software for database management, use searching data and information contained in electronic publications in the field of medicine, pharmacy and pharmacology; content management system (CMS) comprised of components, such as computer hardware and downloadable software for managing search engine content; downloadable management information system [MIS] software; downloadable web application software for database management; downloadable software applications for database management; downloadable data stored in electronic form namely, data sets in the field of medicine, pharmacy and pharmacology, recorded on computer media;downloadable data stored in digital form, namely, data sets in the field of medicine, pharmacy and pharmacology; information stored in electronic, digital and magnetic form, namely, data sets in the field of medicine, pharmacy and pharmacology, recorded on computer media; apparatus for storage of information, namely, blank electronic storage media; information storage apparatus and equipment, namely, blank digital storage media; apparatus and equipment for recording, transmitting or storing information, data, sound or images; teaching apparatus and instruments, namely, microscopes; publications in electronic form, supplied on-line from databases or from facilities provided on the Internet, namely, books, journals, magazines, teaching and reference materials in the field of medicine, pharmacy and pharmacology; electronic databases in the field of medicine, pharmacy and pharmacology, recorded on computer media; CD ROMs containing published materials, namely, namely, books, journals, magazines, teaching and reference materials in the field of medicine, pharmacy and pharmacology, recorded on computer media; electronic data processing equipment and apparatus, namely, blank USB cards; video tapes and discs; audio tapes and discs; parts and fittings for all the aforesaid goodsACTIVE—
016Printed matter and published matter, namely, books; journals; magazines; instructional, teaching and reference published material, namely, books, journals, magazines, in the field of medicine, pharmacy and pharmacology; published material, namely, books, journals, magazines, instructional, teaching and reference materials relating to medicine and pharmacology; parts and fittings for all the aforesaid goodsACTIVE—
041Providing online electronic publications, namely, books, brochures, journals, instructional, teaching and reference materials, all relating to medicine, pharmacy and pharmacology; digital video, audio, and multimedia publishing services; digital video, audio, and multimedia publishing services provided by means of the Internet and world-wide web; online educational and training services, namely, providing classes, seminars and workshops about healthcare and pharmaceuticals; information, advisory and consultancy services relating to the aforesaid servicesACTIVE—
044Providing medical, pharmaceutical or healthcare information; pharmacy advisory services, namely, providing information to patients in the field of health and health care; medical advisory services; provision of information relating to pharmacy or medicine; healthcare information services; providing information regarding medicine and pharmacology by means of the Internet; providing information on medicine and pharmacology for the purposes of updating existing databases by means of the Internet; medical services; hygienic and beauty care for human beings; information, advisory and consultancy services relating to the aforesaid servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 14, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 27, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 27, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Nov 15, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 10, 2025XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Sep 10, 2025XXCRGENERIC MADRID TRANSACTION CREATED—
May 21, 2025CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
May 12, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 11, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Feb 11, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 24, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 24, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 18, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 2, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 2, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Dec 2, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 2, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 2, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 29, 2024CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Nov 29, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 26, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 26, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 23, 2024RFNTREFUSAL PROCESSED BY IB—
Nov 18, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 18, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Nov 18, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 18, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 18, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 18, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 30, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 30, 2024RFRRREFUSAL PROCESSED BY MPU—
Oct 23, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 22, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 18, 2024DOCKASSIGNED TO EXAMINER—
Oct 11, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 11, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 3, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance